Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Uterine Cervical Neoplasms 2Vulvar Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Anus Neoplasms 1

Interventions

Trastuzumab 3Docetaxel 3Biopsy 3trastuzumab deruxtecan 2pembrolizumab 2Vorinostat 2Taxes 2SS1(dsFv)PE38 2Polymerase Chain Reaction 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Flow Cytometry 2zanidatamab 1tipifarnib 1tanespimycin 1spartalizumab 1sargramostim 1pertuzumab 1oncogene protein E7, Human papillomavirus type 16 1neratinib 1entrectinib 1entinostat 1ceralasertib 1alectinib 1aldesleukin 1Specimen Handling 1Ritonavir 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × E6 protein, Human papillomavirus type 16 × Gynecologic × Clear all
NCT00019110 2015-04-29

Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer

National Cancer Institute (NCI)

Phase 1 Completed
CNSGastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Salivary Gland Neoplasms, Vulvar Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡